High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2017, Vol.66 (1), p.S306-S307
Main Authors: Serfaty, L, Pianko, S, Ari, Z.B, Laursen, A.L, Hansen, J, Gane, E.J, Huang, H.-C, Jin, S, Bourque, J, Liu, H, Grandhi, A, Su, M, Gendrano, N, Fernsler, D, Dutko, F, Nguyen, B.-Y.T, Wahl, J, Barr, E, Yeh, W, Plank, R, Butterton, J.R
Format: Article
Language:English
Subjects:
Gastroenterology and Hepatology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
DOI:10.1016/S0168-8278(17)30931-5